Fresenius SE & Co KGaA (FRE) Given a €81.85 Price Target at Berenberg Bank

Berenberg Bank set a €81.85 ($95.17) target price on Fresenius SE & Co KGaA (FRA:FRE) in a report published on Friday. The brokerage currently has a buy rating on the stock.

FRE has been the subject of a number of other research reports. Jefferies Financial Group set a €59.00 ($68.60) price target on Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Monday, October 1st. Independent Research set a €62.00 ($72.09) price target on Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Wednesday, October 31st. Nord/LB set a €75.00 ($87.21) price target on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Thursday, November 1st. Cfra set a €76.00 ($88.37) price target on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Tuesday, October 2nd. Finally, Commerzbank set a €83.00 ($96.51) price target on Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Tuesday, September 11th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of €71.89 ($83.60).

FRE stock opened at €48.99 ($56.97) on Friday. Fresenius SE & Co KGaA has a 12-month low of €60.16 ($69.95) and a 12-month high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Story: Short Selling Stocks, A Beginner’s Guide

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply